Will Insurance or a Scheme — Pay for Sorafenib?

Not automatically under the national benefit package, because PM-JAY was designed around hospitalization and sorafenib is an oral drug taken at home. Some states have extended their scheme to include oral chemotherapy, and both Telangana and Andhra Pradesh have amended their state health programmes over time. The only way to know for certain is to ask the billing team at a PM-JAY empanelled hospital whether sorafenib is currently listed for your cancer type under your state's implementation.

CGHS generally reimburses medicines on the National List of Essential Medicines when prescribed by a CGHS-empanelled specialist under a valid referral. Sorafenib is listed on the NLEM, which supports a reimbursement claim. You will need the referral letter, the specialist's prescription, and pharmacy receipts. Check with your CGHS wellness centre about the exact current procedure — reimbursement rules are updated periodically, and the process differs between serving employees and pensioners.

Possibly, if he earns below the ESIC wage ceiling and his employer contributes to ESIC. Cancer treatment under ESIC starts with a referral from the nearest ESIC dispensary to an approved specialist centre. If the referral is granted, treatment costs including drugs at the approved centre may be covered. Bring his ESIC card and the oncologist's letter to the local ESIC branch office to begin the referral process.

The price difference between branded and generic sorafenib in India is substantial, but we cannot state a figure here because drug prices change and are subject to government price controls under the Drug Price Control Order. The National Pharmaceutical Pricing Authority publishes ceiling prices for controlled medicines. Ask your oncologist or hospital pharmacist for the current cost of both options and whether a generic is clinically appropriate for your treatment.

Bayer has operated patient assistance programmes for Nexavar in India, but availability, eligibility criteria and application routes change over time. Your oncologist's team or hospital social worker will know whether a programme is currently accepting applications. It is worth asking at your first appointment — these programmes are not widely advertised, and applying through the treating clinic is usually the most reliable route.

Ask three things: whether the hospital is empanelled under PM-JAY or Aarogyasri and whether sorafenib is covered for your indication under the current state extension; whether there is an oncology social worker you can see the same day to check NGO or manufacturer assistance; and what the current price difference is between branded and generic sorafenib. Write the answers down — these conversations are difficult to remember under stress, and the answers will shape your next steps.